![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » St. Jude Launches Optis in Europe, Japan
St. Jude Launches Optis in Europe, Japan
![](https://www.fdanews.com/ext/resources/test/Device_Images2/St-Jude-Medical.gif?t=1448910140&width=430)
February 8, 2016
St. Jude Medical has launched its Optis mobile system in Japan and Europe.
The diagnostic system is designed to couple optical coherence tomography and angiography co-registration with fractional flow reserve technology for hospitals with multiple catheterization labs.
The latest Optis system offers physicians a way to optimize percutaneous coronary intervention procedures to treat vascular disease by combining diagnostic tools designed to improve patient outcomes into a portable device, the company said. — Jonathon Shacat
Upcoming Events
-
21Oct